Two grants from the National Institute of Allergies and Infectious Diseases (NIAID), a four-year $3.2 million award and a 12-month $550,000 administrative supplement, will support innovative research to advance the understanding of how climate change and extreme weather influence HIV-related health outcomes around the world.
A CAR-T deal in China; Zevra’s $60M offering
Plus, news about Arrowhead, Cullinan Therapeutics, Cytokinetics, Zentalis, Inovio and Mind Medicine: Domestic biotech M&A in China: Northeast Pharmaceutical Group, a decades-old maker of generics